MRC1 and neoplasm: Out of 17 cases where PD-L1 expression in primary TCAFs was carried out, 4 cases had no PD-L1 (<1% PD-L1 positivity) despite their PD-L1 positivity in tumor tissue, and all 4 of the tumors were MMR-proficient.